facebook pixel
@Novartis
BREAKING: Phase III results are being presented today at #ESMO18 for a new potential treatment option in HR+/HER2- metastatic breast cancer. Learn more: t.co/PsdEspku19 #NovartisNews

 49

 16

 3

Credits
    Tags, Events, and Projects
    • novartisnews
    • esmo18